<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32512809</PMID><DateCompleted><Year>2021</Year><Month>02</Month><Day>19</Day></DateCompleted><DateRevised><Year>2021</Year><Month>02</Month><Day>19</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>11</Issue><PubDate><Year>2020</Year><Month>Jun</Month><Day>04</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Cell-Clearing Systems Bridging Repeat Expansion Proteotoxicity and Neuromuscular Junction Alterations in ALS and SBMA.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">4021</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms21114021</ELocationID><Abstract><AbstractText>The coordinated activities of autophagy and the ubiquitin proteasome system (UPS) are key to preventing the aggregation and toxicity of misfold-prone proteins which manifest in a number of neurodegenerative disorders. These include proteins which are encoded by genes containing nucleotide repeat expansions. In the present review we focus on the overlapping role of autophagy and the UPS in repeat expansion proteotoxicity associated with chromosome 9 open reading frame 72 (<i>C9ORF72</i>) and androgen receptor (<i>AR</i>) genes, which are implicated in two motor neuron disorders, amyotrophic lateral sclerosis (ALS) and spinal-bulbar muscular atrophy (SBMA), respectively. At baseline, both C9ORF72 and AR regulate autophagy, while their aberrantly-expanded isoforms may lead to a failure in both autophagy and the UPS, further promoting protein aggregation and toxicity within motor neurons and skeletal muscles. Besides proteotoxicity, autophagy and UPS alterations are also implicated in neuromuscular junction (NMJ) alterations, which occur early in both ALS and SBMA. In fact, autophagy and the UPS intermingle with endocytic/secretory pathways to regulate axonal homeostasis and neurotransmission by interacting with key proteins which operate at the NMJ, such as agrin, acetylcholine receptors (AChRs), and adrenergic beta2 receptors (B2-ARs). Thus, alterations of autophagy and the UPS configure as a common hallmark in both ALS and SBMA disease progression. The findings here discussed may contribute to disclosing overlapping molecular mechanisms which are associated with a failure in cell-clearing systems in ALS and SBMA.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Limanaqi</LastName><ForeName>Fiona</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0003-0185-2099</Identifier><AffiliationInfo><Affiliation>Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Via Roma 55, 56126 Pisa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Busceti</LastName><ForeName>Carla Letizia</ForeName><Initials>CL</Initials><AffiliationInfo><Affiliation>I.R.C.C.S. Neuromed, Via Atinense, 18, 86077 Pozzilli, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Biagioni</LastName><ForeName>Francesca</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0003-3566-4889</Identifier><AffiliationInfo><Affiliation>I.R.C.C.S. Neuromed, Via Atinense, 18, 86077 Pozzilli, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cantini</LastName><ForeName>Federica</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Via Roma 55, 56126 Pisa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lenzi</LastName><ForeName>Paola</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-4734-8798</Identifier><AffiliationInfo><Affiliation>Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Via Roma 55, 56126 Pisa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fornai</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-3883-5084</Identifier><AffiliationInfo><Affiliation>Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Via Roma 55, 56126 Pisa, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>I.R.C.C.S. Neuromed, Via Atinense, 18, 86077 Pozzilli, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>Ricerca Corrente 2020</GrantID><Agency>Ministero della Salute</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>06</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000073885">C9orf72 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C568651">C9orf72 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.25.1</RegistryNumber><NameOfSubstance UI="D046988">Proteasome Endopeptidase Complex</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001343" MajorTopicYN="N">Autophagy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073885" MajorTopicYN="N">C9orf72 Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D042622" MajorTopicYN="N">DNA Repeat Expansion</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004198" MajorTopicYN="N">Disease Susceptibility</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009134" MajorTopicYN="N">Muscular Atrophy, Spinal</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009469" MajorTopicYN="N">Neuromuscular Junction</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D046988" MajorTopicYN="N">Proteasome Endopeptidase Complex</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">AR</Keyword><Keyword MajorTopicYN="N">C9ORF72</Keyword><Keyword MajorTopicYN="N">GSK3b</Keyword><Keyword MajorTopicYN="N">HSPB8</Keyword><Keyword MajorTopicYN="N">TFEB</Keyword><Keyword MajorTopicYN="N">autophagy</Keyword><Keyword MajorTopicYN="N">beta2 adrenergic receptors</Keyword><Keyword MajorTopicYN="N">mTOR</Keyword><Keyword MajorTopicYN="N">nicotinic acetylcholine receptors</Keyword><Keyword MajorTopicYN="N">proteasome</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>5</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>5</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>6</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>6</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>6</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>2</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32512809</ArticleId><ArticleId IdType="pmc">PMC7312203</ArticleId><ArticleId IdType="doi">10.3390/ijms21114021</ArticleId><ArticleId IdType="pii">ijms21114021</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Madeo F., Eisenberg T., Kroemer G. Autophagy for the avoidance of neurodegeneration. Genes Dev. 2009;23:2253&#x2013;2259. doi: 10.1101/gad.1858009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.1858009</ArticleId><ArticleId IdType="pmc">PMC2758740</ArticleId><ArticleId IdType="pubmed">19797764</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciechanover A., Kwon Y.T. Degradation of misfolded proteins in neurodegenerative diseases: Therapeutic targets and strategies. Exp. Mol. Med. 2015;47:e147. doi: 10.1038/emm.2014.117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emm.2014.117</ArticleId><ArticleId IdType="pmc">PMC4351408</ArticleId><ArticleId IdType="pubmed">25766616</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryskalin L., Busceti C.L., Limanaqi F., Biagioni F., Gambardella S., Fornai F. A Focus on the Beneficial Effects of Alpha Synuclein and a Re-Appraisal of Synucleinopathies. Curr. Protein Pept. Sci. 2018;19:598&#x2013;611. doi: 10.2174/1389203718666171117110028.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1389203718666171117110028</ArticleId><ArticleId IdType="pmc">PMC5925871</ArticleId><ArticleId IdType="pubmed">29150919</ArticleId></ArticleIdList></Reference><Reference><Citation>Limanaqi F., Biagioni F., Gambardella S., Familiari P., Frati A., Fornai F. Promiscuous Roles of Autophagy and Proteasome in Neurodegenerative Proteinopathies. Int. J. Mol. Sci. 2020;21:3028. doi: 10.3390/ijms21083028.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21083028</ArticleId><ArticleId IdType="pmc">PMC7215558</ArticleId><ArticleId IdType="pubmed">32344772</ArticleId></ArticleIdList></Reference><Reference><Citation>Jimenez-Sanchez M., Thomson F., Zavodszky E., Rubinsztein D.C. Autophagy and polyglutamine diseases. Prog. Neurobiol. 2012;97:67&#x2013;82. doi: 10.1016/j.pneurobio.2011.08.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2011.08.013</ArticleId><ArticleId IdType="pmc">PMC3712188</ArticleId><ArticleId IdType="pubmed">21930185</ArticleId></ArticleIdList></Reference><Reference><Citation>Pearce M.M.P., Kopito R.R. Prion-Like Characteristics of Polyglutamine-Containing Proteins. Cold Spring Harb. Perspect. Med. 2018;8:a024257. doi: 10.1101/cshperspect.a024257.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a024257</ArticleId><ArticleId IdType="pmc">PMC5793740</ArticleId><ArticleId IdType="pubmed">28096245</ArticleId></ArticleIdList></Reference><Reference><Citation>Babi&#x107; Leko M., &#x17d;upunski V., Kirincich J., Smilovi&#x107; D., Hortob&#xe1;gyi T., Hof P.R., &#x160;imi&#x107; G. Molecular Mechanisms of Neurodegeneration Related to C9orf72 Hexanucleotide Repeat Expansion. Behav. Neurol. 2019;2019:2909168. doi: 10.1155/2019/2909168.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2019/2909168</ArticleId><ArticleId IdType="pmc">PMC6350563</ArticleId><ArticleId IdType="pubmed">30774737</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies J.E., Sarkar S., Rubinsztein D.C. The ubiquitin proteasome system in Huntington&#x2019;s disease and the spinocerebellar ataxias. BMC Biochem. 2007;8(Suppl. 1):S2. doi: 10.1186/1471-2091-8-S1-S2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2091-8-S1-S2</ArticleId><ArticleId IdType="pmc">PMC2106366</ArticleId><ArticleId IdType="pubmed">18047739</ArticleId></ArticleIdList></Reference><Reference><Citation>Abel A., Walcott J., Woods J., Duda J., Merry D.E. Expression of expanded repeat androgen receptor produces neurologic disease in transgenic mice. Hum. Mol. Genet. 2001;10:107&#x2013;116. doi: 10.1093/hmg/10.2.107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/10.2.107</ArticleId><ArticleId IdType="pubmed">11152658</ArticleId></ArticleIdList></Reference><Reference><Citation>Cicardi M.E., Cristofani R., Crippa V., Ferrari V., Tedesco B., Casarotto E., Chierichetti M., Galbiati M., Piccolella M., Messi E., et al. Autophagic and Proteasomal Mediated Removal of Mutant Androgen Receptor in Muscle Models of Spinal and Bulbar Muscular Atrophy. Front. Endocrinol. (Lausanne) 2019;10:569. doi: 10.3389/fendo.2019.00569.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2019.00569</ArticleId><ArticleId IdType="pmc">PMC6710630</ArticleId><ArticleId IdType="pubmed">31481932</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Blitterswijk M., DeJesus-Hernandez M., Rademakers R. How do C9ORF72 repeat expansions cause amyotrophic lateral sclerosis and frontotemporal dementia: Can we learn from other noncoding repeat expansion disorders? Curr. Opin. Neurol. 2012;25:689&#x2013;700. doi: 10.1097/WCO.0b013e32835a3efb.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WCO.0b013e32835a3efb</ArticleId><ArticleId IdType="pmc">PMC3923493</ArticleId><ArticleId IdType="pubmed">23160421</ArticleId></ArticleIdList></Reference><Reference><Citation>La Spada A.R., Wilson E.M., Lubahn D.B., Harding A.E., Fischbeck K.H. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature. 1991;352:77&#x2013;79. doi: 10.1038/352077a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/352077a0</ArticleId><ArticleId IdType="pubmed">2062380</ArticleId></ArticleIdList></Reference><Reference><Citation>Parboosingh J.S., Figlewicz D.A., Krizus A., Meininger V., Azad N.A., Newman D.S., Rouleau G.A. Spinobulbar muscular atrophy can mimic ALS: The importance of genetic testing in male patients with atypical ALS. Neurology. 1997;49:568&#x2013;572. doi: 10.1212/WNL.49.2.568.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.49.2.568</ArticleId><ArticleId IdType="pubmed">9270598</ArticleId></ArticleIdList></Reference><Reference><Citation>Pradat P.F. SBMA: A rare disease but a classic ALS mimic syndrome. Presse Med. 2014;43:580&#x2013;586. doi: 10.1016/j.lpm.2014.03.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lpm.2014.03.005</ArticleId><ArticleId IdType="pubmed">24785145</ArticleId></ArticleIdList></Reference><Reference><Citation>Carnio S., LoVerso F., Baraibar M.A., Longa E., Khan M.M., Maffei M., Reischl M., Canepari M., Loefler S., Kern H., et al. Autophagy impairment in muscle induces neuromuscular junction degeneration and precocious aging. Cell Rep. 2014;8:1509&#x2013;1521. doi: 10.1016/j.celrep.2014.07.061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2014.07.061</ArticleId><ArticleId IdType="pmc">PMC4534571</ArticleId><ArticleId IdType="pubmed">25176656</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik B., Devine H., Patani R., La Spada A.R., Hanna M.G., Greensmith L. Gene expression analysis reveals early dysregulation of disease pathways and links Chmp7 to pathogenesis of spinal and bulbar muscular atrophy. Sci. Rep. 2019;9:3539. doi: 10.1038/s41598-019-40118-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-40118-3</ArticleId><ArticleId IdType="pmc">PMC6401132</ArticleId><ArticleId IdType="pubmed">30837566</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudnick N.D., Griffey C.J., Guarnieri P., Gerbino V., Wang X., Piersaint J.A., Tapia J.C., Rich M.M., Maniatis T. Distinct roles for motor neuron autophagy early and late in the SOD1G93A mouse model of ALS. Proc. Natl. Acad. Sci. USA. 2017;114:E8294&#x2013;E8303. doi: 10.1073/pnas.1704294114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1704294114</ArticleId><ArticleId IdType="pmc">PMC5625902</ArticleId><ArticleId IdType="pubmed">28904095</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Q., Jiang J., Gendron T.F., McAlonis-Downes M., Jiang L., Taylor A., Diaz Garcia S., Ghosh Dastidar S., Rodriguez M.J., King P., et al. Reduced C9ORF72 function exacerbates gain of toxicity from ALS/FTD-causing repeat expansion in C9orf72. Nat. Neurosci. 2020 doi: 10.1038/s41593-020-0619-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-0619-5</ArticleId><ArticleId IdType="pmc">PMC7384305</ArticleId><ArticleId IdType="pubmed">32284607</ArticleId></ArticleIdList></Reference><Reference><Citation>Khosravi B., LaClair K.D., Riemenschneider H., Zhou Q., Frottin F., Mareljic N., Czuppa M., Farny D., Hartmann H., Michaelsen M., et al. Cell-to-cell transmission of C9orf72 poly-(Gly-Ala) triggers key features of ALS/FTD. EMBO J. 2020;39:e102811. doi: 10.15252/embj.2019102811.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.2019102811</ArticleId><ArticleId IdType="pmc">PMC7156967</ArticleId><ArticleId IdType="pubmed">32175624</ArticleId></ArticleIdList></Reference><Reference><Citation>Boivin M., Pfister V., Gaucherot A., Ruffenach F., Negroni L., Sellier C., Charlet-Berguerand N. Reduced autophagy upon C9ORF72 loss synergizes with dipeptide repeat protein toxicity in G4C2 repeat expansion disorders. EMBO J. 2020;39:e100574. doi: 10.15252/embj.2018100574.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.2018100574</ArticleId><ArticleId IdType="pmc">PMC7024836</ArticleId><ArticleId IdType="pubmed">31930538</ArticleId></ArticleIdList></Reference><Reference><Citation>Cristofani R., Crippa V., Rusmini P., Cicardi M.E., Meroni M., Licata N.V., Sala G., Giorgetti E., Grunseich C., Galbiati M., et al. Inhibition of retrograde transport modulates misfolded protein accumulation and clearance in motoneuron diseases. Autophagy. 2017;13:1280&#x2013;1303. doi: 10.1080/15548627.2017.1308985.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2017.1308985</ArticleId><ArticleId IdType="pmc">PMC5584856</ArticleId><ArticleId IdType="pubmed">28402699</ArticleId></ArticleIdList></Reference><Reference><Citation>Webster C.P., Smith E.F., Bauer C.S., Moller A., Hautbergue G.M., Ferraiuolo L., Myszczynska M.A., Higginbottom A., Walsh M.J., Whitworth A.J., et al. The C9orf72 protein interacts with Rab1a and the ULK1 complex to regulate initiation of autophagy. EMBO J. 2016;35:1656&#x2013;1676. doi: 10.15252/embj.201694401.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201694401</ArticleId><ArticleId IdType="pmc">PMC4969571</ArticleId><ArticleId IdType="pubmed">27334615</ArticleId></ArticleIdList></Reference><Reference><Citation>Cortes C.J., Miranda H.C., Frankowski H., Batlevi Y., Young J.E., Le A., Ivanov N., Sopher B.L., Carromeu C., Muotri A.R., et al. Polyglutamine-expanded androgen receptor interferes with TFEB to elicit autophagy defects in SBMA. Nat. Neurosci. 2014;17:1180&#x2013;1189. doi: 10.1038/nn.3787.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3787</ArticleId><ArticleId IdType="pmc">PMC4180729</ArticleId><ArticleId IdType="pubmed">25108912</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta R., Lan M., Mojsilovic-Petrovic J., Choi W.H., Safren N., Barmada S., Lee M.J., Kalb R. The Proline/Arginine Dipeptide from Hexanucleotide Repeat Expanded C9ORF72 Inhibits the Proteasome. eNeuro. 2017;4 doi: 10.1523/ENEURO.0249-16.2017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/ENEURO.0249-16.2017</ArticleId><ArticleId IdType="pmc">PMC5282547</ArticleId><ArticleId IdType="pubmed">28197542</ArticleId></ArticleIdList></Reference><Reference><Citation>Thibaudeau T.A., Anderson R.T., Smith D.M. A common mechanism of proteasome impairment by neurodegenerative disease-associated oligomers. Nat. Commun. 2018;9:1097. doi: 10.1038/s41467-018-03509-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-03509-0</ArticleId><ArticleId IdType="pmc">PMC5854577</ArticleId><ArticleId IdType="pubmed">29545515</ArticleId></ArticleIdList></Reference><Reference><Citation>Abo-Rady M., Kalmbach N., Pal A., Schludi C., Janosch A., Richter T., Freitag P., Bickle M., Kahlert A.K., Petri S., et al. Knocking out C9ORF72 Exacerbates Axonal Trafficking Defects Associated with Hexanucleotide Repeat Expansion and Reduces Levels of Heat Shock Proteins. Stem Cell Rep. 2020;14:390&#x2013;405. doi: 10.1016/j.stemcr.2020.01.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2020.01.010</ArticleId><ArticleId IdType="pmc">PMC7066330</ArticleId><ArticleId IdType="pubmed">32084385</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas P.S., Jr., Fraley G.S., Damian V., Woodke L.B., Zapata F., Sopher B.L., Plymate S.R., La Spada A.R. Loss of endogenous androgen receptor protein accelerates motor neuron degeneration and accentuates androgen insensitivity in a mouse model of X-linked spinal and bulbar muscular atrophy. Hum. Mol. Genet. 2006;15:2225&#x2013;2238. doi: 10.1093/hmg/ddl148.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddl148</ArticleId><ArticleId IdType="pubmed">16772330</ArticleId></ArticleIdList></Reference><Reference><Citation>Blessing A.M., Rajapakshe K., Reddy Bollu L., Shi Y., White M.A., Pham A.H., Lin C., Jonsson P., Cortes C.J., Cheung E., et al. Transcriptional regulation of core autophagy and lysosomal genes by the androgen receptor promotes prostate cancer progression. Autophagy. 2017;13:506&#x2013;521. doi: 10.1080/15548627.2016.1268300.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2016.1268300</ArticleId><ArticleId IdType="pmc">PMC5361609</ArticleId><ArticleId IdType="pubmed">27977328</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciura S., Sellier C., Campanari M.L., Charlet-Berguerand N., Kabashi E. The most prevalent genetic cause of ALS-FTD, C9orf72 synergizes the toxicity of ATXN2 intermediate polyglutamine repeats through the autophagy pathway. Autophagy. 2016;12:1406&#x2013;1408. doi: 10.1080/15548627.2016.1189070.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2016.1189070</ArticleId><ArticleId IdType="pmc">PMC4968221</ArticleId><ArticleId IdType="pubmed">27245636</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasquali L., Ruffoli R., Fulceri F., Pietracupa S., Siciliano G., Paparelli A., Fornai F. The role of autophagy: What can be learned from the genetic forms of amyotrophic lateral sclerosis. CNS Neurol. Disord. Drug Targets. 2010;9:268&#x2013;278. doi: 10.2174/187152710791292594.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/187152710791292594</ArticleId><ArticleId IdType="pubmed">20406184</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrucci M., Fulceri F., Toti L., Soldani P., Siciliano G., Paparelli A., Fornai F. Protein clearing pathways in ALS. Arch. Ital. Biol. 2011;149:121&#x2013;149. doi: 10.4449/aib.v149i1.1258.</Citation><ArticleIdList><ArticleId IdType="doi">10.4449/aib.v149i1.1258</ArticleId><ArticleId IdType="pubmed">21412721</ArticleId></ArticleIdList></Reference><Reference><Citation>Maurel C., Dangoumau A., Marouillat S., Brulard C., Chami A., Hergesheimer R., Corcia P., Blasco H., Andres C.R., Vourc&#x2019;h P. Causative Genes in Amyotrophic Lateral Sclerosis and Protein Degradation Pathways: A Link to Neurodegeneration. Mol. Neurobiol. 2018;55:6480&#x2013;6499. doi: 10.1007/s12035-017-0856-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-017-0856-0</ArticleId><ArticleId IdType="pubmed">29322304</ArticleId></ArticleIdList></Reference><Reference><Citation>Manzano R., Sorar&#xfa; G., Grunseich C., Fratta P., Zuccaro E., Pennuto M., Rinaldi C. Beyond motor neurons: Expanding the clinical spectrum in Kennedy&#x2019;s disease. J. Neurol. Neurosurg. Psychiatry. 2018;89:808&#x2013;812. doi: 10.1136/jnnp-2017-316961.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2017-316961</ArticleId><ArticleId IdType="pmc">PMC6204939</ArticleId><ArticleId IdType="pubmed">29353237</ArticleId></ArticleIdList></Reference><Reference><Citation>Starr A., Sattler R. Synaptic dysfunction and altered excitability in C9ORF72 ALS/FTD. Brain Res. 2018;1693:98&#x2013;108. doi: 10.1016/j.brainres.2018.02.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2018.02.011</ArticleId><ArticleId IdType="pmc">PMC5997509</ArticleId><ArticleId IdType="pubmed">29453960</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Y., Halievski K., Henley C., Atchison W.D., Katsuno M., Adachi H., Sobue G., Breedlove S.M., Jordan C.L. Defects in Neuromuscular Transmission May Underlie Motor Dysfunction in Spinal and Bulbar Muscular Atrophy. J. Neurosci. 2016;36:5094&#x2013;5106. doi: 10.1523/JNEUROSCI.3485-15.2016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3485-15.2016</ArticleId><ArticleId IdType="pmc">PMC4854970</ArticleId><ArticleId IdType="pubmed">27147661</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis L., Echaniz-Laguna A. Skeletal muscle in motor neuron diseases: Therapeutic target and delivery route for potential treatments. Curr. Drug Targets. 2010;11:1250&#x2013;1261. doi: 10.2174/1389450111007011250.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1389450111007011250</ArticleId><ArticleId IdType="pmc">PMC4834127</ArticleId><ArticleId IdType="pubmed">20840067</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark J.A., Southam K.A., Blizzard C.A., King A.E., Dickson T.C. Axonal degeneration, distal collateral branching and neuromuscular junction architecture alterations occur prior to symptom onset in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis. J. Chem. Neuroanat. 2016;76:35&#x2013;47. doi: 10.1016/j.jchemneu.2016.03.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jchemneu.2016.03.003</ArticleId><ArticleId IdType="pubmed">27038603</ArticleId></ArticleIdList></Reference><Reference><Citation>Onodera K., Shimojo D., Ishihara Y., Yano M., Miya F., Banno H., Kuzumaki N., Ito T., Okada R., de Ara&#xfa;jo Herculano B., et al. Unveiling synapse pathology in spinal bulbar muscular atrophy by genome-wide transcriptome analysis of purified motor neurons derived from disease specific iPSCs. Mol. Brain. 2020;13:18. doi: 10.1186/s13041-020-0561-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13041-020-0561-1</ArticleId><ArticleId IdType="pmc">PMC7029484</ArticleId><ArticleId IdType="pubmed">32070397</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen D.N., Zhang L.H., Wei E.Q., Yang Y. Autophagy in synaptic development, function, and pathology. Neurosci. Bull. 2015;31:416&#x2013;426. doi: 10.1007/s12264-015-1536-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12264-015-1536-6</ArticleId><ArticleId IdType="pmc">PMC5563709</ArticleId><ArticleId IdType="pubmed">26139541</ArticleId></ArticleIdList></Reference><Reference><Citation>Uytterhoeven V., Lauwers E., Maes I., Miskiewicz K., Melo M.N., Swerts J., Kuenen S., Wittocx R., Corthout N., Marrink S.J., et al. Hsc70-4 Deforms Membranes to Promote Synaptic Protein Turnover by Endosomal Microautophagy. Neuron. 2015;88:735&#x2013;748. doi: 10.1016/j.neuron.2015.10.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2015.10.012</ArticleId><ArticleId IdType="pubmed">26590345</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding M., Shen K. The role of the ubiquitin proteasome system in synapse remodeling and neurodegenerative diseases. Bioessays. 2008;30:1075&#x2013;1083. doi: 10.1002/bies.20843.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bies.20843</ArticleId><ArticleId IdType="pmc">PMC3095215</ArticleId><ArticleId IdType="pubmed">18937340</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhattacharyya B.J., Wilson S.M., Jung H., Miller R.J. Altered neurotransmitter release machinery in mice deficient for the deubiquitinating enzyme Usp14. Am. J. Physiol. Cell. Physiol. 2012;302:C698&#x2013;C708. doi: 10.1152/ajpcell.00326.2010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpcell.00326.2010</ArticleId><ArticleId IdType="pmc">PMC3287356</ArticleId><ArticleId IdType="pubmed">22075695</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang S.J., Li X.X., Yu Y., Chiu A.P., Lo L.H., To J.C., Rowlands D.K., Keng V.W. Schwann cell-specific PTEN and EGFR dysfunctions affect neuromuscular junction development by impairing Agrin signaling and autophagy. Biochem. Biophys. Res. Commun. 2019;515:50&#x2013;56. doi: 10.1016/j.bbrc.2019.05.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2019.05.014</ArticleId><ArticleId IdType="pubmed">31122699</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudolf R., Straka T. Nicotinic acetylcholine receptor at vertebrate motor endplates: Endocytosis, recycling, and degradation. Neurosci. Lett. 2019;711:134434. doi: 10.1016/j.neulet.2019.134434.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2019.134434</ArticleId><ArticleId IdType="pubmed">31421156</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudolf R., Deschenes M.R., Sandri M. Neuromuscular junction degeneration in muscle wasting. Curr. Opin. Clin. Nutr. Metab. Care. 2016;19:177&#x2013;181. doi: 10.1097/MCO.0000000000000267.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MCO.0000000000000267</ArticleId><ArticleId IdType="pmc">PMC4946244</ArticleId><ArticleId IdType="pubmed">26870889</ArticleId></ArticleIdList></Reference><Reference><Citation>Ar&#xe1;nguiz-Urroz P., Canales J., Copaja M., Troncoso R., Vicencio J.M., Carrillo C., Lara H., Lavandero S., D&#xed;az-Araya G. Beta(2)-adrenergic receptor regulates cardiac fibroblast autophagy and collagen degradation. Biochim. Biophys. Acta. 2011;1812:23&#x2013;31. doi: 10.1016/j.bbadis.2010.07.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2010.07.003</ArticleId><ArticleId IdType="pubmed">20637865</ArticleId></ArticleIdList></Reference><Reference><Citation>Lynch E., Semrad T., Belsito V.S., FitzGibbons C., Reilly M., Hayakawa K., Suzuki M. C9ORF72-related cellular pathology in skeletal myocytes derived from ALS-patient induced pluripotent stem cells. Dis. Model Mech. 2019;12:dmm039552. doi: 10.1242/dmm.039552.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.039552</ArticleId><ArticleId IdType="pmc">PMC6737948</ArticleId><ArticleId IdType="pubmed">31439573</ArticleId></ArticleIdList></Reference><Reference><Citation>Cykowski M.D., Powell S.Z., Appel J.W., Arumanayagam A.S., Rivera A.L., Appel S.H. Phosphorylated TDP-43 (pTDP-43) aggregates in the axial skeletal muscle of patients with sporadic and familial amyotrophic lateral sclerosis. Acta Neuropathol. Commun. 2018;6:28. doi: 10.1186/s40478-018-0528-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-018-0528-y</ArticleId><ArticleId IdType="pmc">PMC5899326</ArticleId><ArticleId IdType="pubmed">29653597</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho W.Y., Tai Y.K., Chang J.C., Liang J., Tyan S.H., Chen S., Guan J.L., Zhou H., Shen H.M., Koo E., et al. The ALS-FTD-linked gene product, C9orf72, regulates neuronal morphogenesis via autophagy. Autophagy. 2019;15:827&#x2013;842. doi: 10.1080/15548627.2019.1569441.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2019.1569441</ArticleId><ArticleId IdType="pmc">PMC6526867</ArticleId><ArticleId IdType="pubmed">30669939</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo Q., Lehmer C., Mart&#xed;nez-S&#xe1;nchez A., Rudack T., Beck F., Hartmann H., P&#xe9;rez-Berlanga M., Frottin F., Hipp M.S., Hartl F.U., et al. In Situ Structure of Neuronal C9orf72 Poly-GA Aggregates Reveals Proteasome Recruitment. Cell. 2018;172:696&#x2013;705.e12. doi: 10.1016/j.cell.2017.12.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2017.12.030</ArticleId><ArticleId IdType="pmc">PMC6035389</ArticleId><ArticleId IdType="pubmed">29398115</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamakawa M., Ito D., Honda T., Kubo K., Noda M., Nakajima K., Suzuki N. Characterization of the dipeptide repeat protein in the molecular pathogenesis of c9FTD/ALS. Hum. Mol. Genet. 2015;24:1630&#x2013;1645. doi: 10.1093/hmg/ddu576.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddu576</ArticleId><ArticleId IdType="pubmed">25398948</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y.J., Gendron T.F., Grima J.C., Sasaguri H., Jansen-West K., Xu Y.F., Katzman R.B., Gass J., Murray M.E., Shinohara M., et al. C9ORF72 poly(GA) aggregates sequester and impair HR23 andnucleocytoplasmic transport proteins. Nat. Neurosci. 2016;19:668&#x2013;677. doi: 10.1038/nn.4272.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4272</ArticleId><ArticleId IdType="pmc">PMC5138863</ArticleId><ArticleId IdType="pubmed">26998601</ArticleId></ArticleIdList></Reference><Reference><Citation>Boeve B.F., Boylan K.B., Graff-Radford N.R., DeJesus-Hernandez M., Knopman D.S., Pedraza O., Vemuri P., Jones D., Lowe V., Murray M.E., et al. Characterization of frontotemporal dementia and/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72. Brain. 2012;135:765&#x2013;783. doi: 10.1093/brain/aws004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/aws004</ArticleId><ArticleId IdType="pmc">PMC3286335</ArticleId><ArticleId IdType="pubmed">22366793</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper-Knock J., Hewitt C., Highley J.R., Brockington A., Milano A., Man S., Martindale J., Hartley J., Walsh T., Gelsthorpe C., et al. Clinico-pathological features in amyotrophic lateral sclerosis with expansions in C9ORF72. Brain. 2012;135:751&#x2013;764. doi: 10.1093/brain/awr365.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr365</ArticleId><ArticleId IdType="pmc">PMC3286332</ArticleId><ArticleId IdType="pubmed">22366792</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Sarraj S., King A., Troakes C., Smith B., Maekawa S., Bodi I., Rogelj B., Al-Chalabi A., Hortob&#xe1;gyi T., Shaw C.E. p62 positive, TDP-43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9orf72-linked FTLD and MND/ALS. Acta Neuropathol. 2011;122:691&#x2013;702. doi: 10.1007/s00401-011-0911-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-011-0911-2</ArticleId><ArticleId IdType="pubmed">22101323</ArticleId></ArticleIdList></Reference><Reference><Citation>Sellier C., Campanari M.L., Julie Corbier C., Gaucherot A., Kolb-Cheynel I., Oulad-Abdelghani M., Ruffenach F., Page A., Ciura S., Kabashi E., et al. Loss of C9ORF72 impairs autophagy and synergizes with polyQ Ataxin-2 to induce motor neuron dysfunction and cell death. EMBO J. 2016;35:1276&#x2013;1297. doi: 10.15252/embj.201593350.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201593350</ArticleId><ArticleId IdType="pmc">PMC4910533</ArticleId><ArticleId IdType="pubmed">27103069</ArticleId></ArticleIdList></Reference><Reference><Citation>van Blitterswijk M., van Es M.A., Hennekam E.A., Dooijes D., van Rheenen W., Medic J., Bourque P.R., Schelhaas H.J., van der Kooi A.J., de Visser M., et al. Evidence for an oligogenic basis of amyotrophic lateral sclerosis. Hum. Mol. Genet. 2012;21:3776&#x2013;3784. doi: 10.1093/hmg/dds199.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/dds199</ArticleId><ArticleId IdType="pubmed">22645277</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratti A., Corrado L., Castellotti B., Del Bo R., Fogh I., Cereda C., Tiloca C., D&#x2019;Ascenzo C., Bagarotti A., Pensato V., et al. C9ORF72 repeat expansion in a large Italian ALS cohort: Evidence of a founder effect. Neurobiol. Aging. 2012;33:e7&#x2013;e14. doi: 10.1016/j.neurobiolaging.2012.06.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2012.06.008</ArticleId><ArticleId IdType="pubmed">22766072</ArticleId></ArticleIdList></Reference><Reference><Citation>Millecamps S., Boill&#xe9;e S., Le Ber I., Seilhean D., Teyssou E., Giraudeau M., Moigneu C., Vandenberghe N., Danel-Brunaud V., Corcia P., et al. Phenotype difference between ALS patients with expanded repeats in C9ORF72 and patients with mutations in other ALS-related genes. J. Med. Genet. 2012;49:258&#x2013;263. doi: 10.1136/jmedgenet-2011-100699.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jmedgenet-2011-100699</ArticleId><ArticleId IdType="pubmed">22499346</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrari R., Mok K., Moreno J.H., Cosentino S., Goldman J., Pietrini P., Mayeux R., Tierney M.C., Kapogiannis D., Jicha G.A., et al. Screening for C9ORF72 repeat expansion in FTLD. Neurobiol. Aging. 2012;33:e1&#x2013;e11. doi: 10.1016/j.neurobiolaging.2012.02.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2012.02.017</ArticleId><ArticleId IdType="pmc">PMC3743244</ArticleId><ArticleId IdType="pubmed">22459598</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Blitterswijk M., Mullen B., Heckman M.G., Baker M.C., DeJesus-Hernandez M., Brown P.H., Murray M.E., Hsiung G.Y., Stewart H., Karydas A.M., et al. Ataxin-2 as potential disease modifier in C9ORF72 expansion carriers. Neurobiol. Aging. 2014;35:e13&#x2013;e17. doi: 10.1016/j.neurobiolaging.2014.04.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2014.04.016</ArticleId><ArticleId IdType="pmc">PMC4105839</ArticleId><ArticleId IdType="pubmed">24866401</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwok C.T., Wang H.Y., Morris A.G., Smith B., Shaw C., de Belleroche J. VCP mutations are not a major cause of familial amyotrophic lateral sclerosis in the UK. J. Neurol. Sci. 2015;349:209&#x2013;213. doi: 10.1016/j.jns.2015.01.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2015.01.021</ArticleId><ArticleId IdType="pubmed">25618255</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;nch C., Rosenbohm A., Sperfeld A.D., Uttner I., Reske S., Krause B.J., Sedlmeier R., Meyer T., Hanemann C.O., Stumm G., et al. Heterozygous R1101K mutation of the DCTN1 gene in a family with ALS and FTD. Ann. Neurol. 2005;58:777&#x2013;780. doi: 10.1002/ana.20631.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.20631</ArticleId><ArticleId IdType="pubmed">16240349</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;nch C., Sedlmeier R., Meyer T., Homberg V., Sperfeld A.D., Kurt A., Prudlo J., Peraus G., Hanemann C.O., Stumm G., et al. Point mutations of the p150 subunit of dynactin (DCTN1) gene in ALS. Neurology. 2004;63:724&#x2013;726. doi: 10.1212/01.WNL.0000134608.83927.B1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.WNL.0000134608.83927.B1</ArticleId><ArticleId IdType="pubmed">15326253</ArticleId></ArticleIdList></Reference><Reference><Citation>Renaud L., Picher-Martel V., Codron P., Julien J.P. Key role of UBQLN2 in pathogenesis of amyotrophic lateral sclerosis and frontotemporal dementia. Acta Neuropathol. Commun. 2019;7:103. doi: 10.1186/s40478-019-0758-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-019-0758-7</ArticleId><ArticleId IdType="pmc">PMC6889556</ArticleId><ArticleId IdType="pubmed">31319884</ArticleId></ArticleIdList></Reference><Reference><Citation>Crippa V., Sau D., Rusmini P., Boncoraglio A., Onesto E., Bolzoni E., Galbiati M., Fontana E., Marino M., Carra S., et al. The small heat shock protein B8 (HspB8) promotes autophagic removal of misfolded proteins involved in amyotrophic lateral sclerosis (ALS) Hum. Mol. Genet. 2010;19:3440&#x2013;3456. doi: 10.1093/hmg/ddq257.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddq257</ArticleId><ArticleId IdType="pubmed">20570967</ArticleId></ArticleIdList></Reference><Reference><Citation>Crippa V., Galbiati M., Boncoraglio A., Rusmini P., Onesto E., Giorgetti E., Cristofani R., Zito A., Poletti A. Motoneuronal and muscle-selective removal of ALS-related misfolded proteins. Biochem. Soc. Trans. 2013;41:1598&#x2013;1604. doi: 10.1042/BST20130118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BST20130118</ArticleId><ArticleId IdType="pubmed">24256261</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X., Fan H., Ying Z., Li B., Wang H., Wang G. Degradation of TDP-43 and its pathogenic form by autophagy and the ubiquitin-proteasome system. Neurosci. Lett. 2010;469:112&#x2013;116. doi: 10.1016/j.neulet.2009.11.055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2009.11.055</ArticleId><ArticleId IdType="pubmed">19944744</ArticleId></ArticleIdList></Reference><Reference><Citation>Scotter E.L., Vance C., Nishimura A.L., Lee Y.B., Chen H.J., Urwin H., Sardone V., Mitchell J.C., Rogelj B., Rubinsztein D.C., et al. Differential roles of the ubiquitin proteasome system and autophagy in the clearance of soluble and aggregated TDP-43 species. J. Cell Sci. 2014;127:1263&#x2013;1278. doi: 10.1242/jcs.140087.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.140087</ArticleId><ArticleId IdType="pmc">PMC3953816</ArticleId><ArticleId IdType="pubmed">24424030</ArticleId></ArticleIdList></Reference><Reference><Citation>Cicardi M.E., Cristofani R., Rusmini P., Meroni M., Ferrari V., Vezzoli G., Tedesco B., Piccolella M., Messi E., Galbiati M., et al. Tdp-25 Routing to Autophagy and Proteasome Ameliorates its Aggregation in Amyotrophic Lateral Sclerosis Target Cells. Sci. Rep. 2018;8:12390. doi: 10.1038/s41598-018-29658-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-29658-2</ArticleId><ArticleId IdType="pmc">PMC6098007</ArticleId><ArticleId IdType="pubmed">30120266</ArticleId></ArticleIdList></Reference><Reference><Citation>Watabe K., Akiyama K., Kawakami E., Ishii T., Endo K., Yanagisawa H., Sango K., Tsukamoto M. Adenoviral expression of TDP-43 and FUS genes and shRNAs for protein degradation pathways in rodent motoneurons in vitro and in vivo. Neuropathology. 2014;34:83&#x2013;98. doi: 10.1111/neup.12058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/neup.12058</ArticleId><ArticleId IdType="pubmed">23937386</ArticleId></ArticleIdList></Reference><Reference><Citation>Marrone L., Drexler H.C.A., Wang J., Tripathi P., Distler T., Heisterkamp P., Anderson E.N., Kour S., Moraiti A., Maharana S., et al. FUS pathology in ALS is linked to alterations in multiple ALS-associated proteins and rescued by drugs stimulating autophagy. Acta Neuropathol. 2019;138:67&#x2013;84. doi: 10.1007/s00401-019-01998-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-019-01998-x</ArticleId><ArticleId IdType="pmc">PMC6570784</ArticleId><ArticleId IdType="pubmed">30937520</ArticleId></ArticleIdList></Reference><Reference><Citation>Fornai F., Longone P., Cafaro L., Kastsiuchenka O., Ferrucci M., Manca M.L., Lazzeri G., Spalloni A., Bellio N., Lenzi P., et al. Lithium delays progression of amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. USA. 2008;105:2052&#x2013;2057. doi: 10.1073/pnas.0708022105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0708022105</ArticleId><ArticleId IdType="pmc">PMC2538879</ArticleId><ArticleId IdType="pubmed">18250315</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu M., Zhang S., Tian X., Wu C. Mask mitigates MAPT- and FUS-induced degeneration by enhancing autophagy through lysosomal acidification. Autophagy. 2017;13:1924&#x2013;1938. doi: 10.1080/15548627.2017.1362524.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2017.1362524</ArticleId><ArticleId IdType="pmc">PMC5788473</ArticleId><ArticleId IdType="pubmed">28806139</ArticleId></ArticleIdList></Reference><Reference><Citation>Harman C.A., Monteiro M.J. The specificity of ubiquitin binding to ubiquilin-1 is regulated by sequences besides its UBA domain. Biochim. Biophys. Acta Gen. Subj. 2019;1863:1568&#x2013;1574. doi: 10.1016/j.bbagen.2019.06.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbagen.2019.06.002</ArticleId><ArticleId IdType="pmc">PMC6679980</ArticleId><ArticleId IdType="pubmed">31175912</ArticleId></ArticleIdList></Reference><Reference><Citation>Hjerpe R., Bett J.S., Keuss M.J., Solovyova A., McWilliams T.G., Johnson C., Sahu I., Varghese J., Wood N., Wightman M., et al. UBQLN2 Mediates Autophagy-Independent Protein Aggregate Clearance by the Proteasome. Cell. 2016;166:935&#x2013;949. doi: 10.1016/j.cell.2016.07.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2016.07.001</ArticleId><ArticleId IdType="pmc">PMC5003816</ArticleId><ArticleId IdType="pubmed">27477512</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x15e;ent&#xfc;rk M., Lin G., Zuo Z., Mao D., Watson E., Mikos A.G., Bellen H.J. Ubiquilins regulate autophagic flux through mTOR signalling and lysosomal acidification. Nat. Cell Biol. 2019;21:384&#x2013;396. doi: 10.1038/s41556-019-0281-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41556-019-0281-x</ArticleId><ArticleId IdType="pmc">PMC6534127</ArticleId><ArticleId IdType="pubmed">30804504</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S.H., Stiles S.G., Feichtmeier J.M., Ramesh N., Zhan L., Scalf M.A., Smith L.M., Pandey U.B., Tibbetts R.S. Mutation-dependent aggregation and toxicity in a Drosophila model for UBQLN2-associated ALS. Hum. Mol. Genet. 2018;27:322&#x2013;337. doi: 10.1093/hmg/ddx403.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddx403</ArticleId><ArticleId IdType="pmc">PMC5886165</ArticleId><ArticleId IdType="pubmed">29161404</ArticleId></ArticleIdList></Reference><Reference><Citation>Osaka M., Ito D., Suzuki N. Disturbance of proteasomal and autophagic protein degradation pathways by amyotrophic lateral sclerosis-linked mutations in ubiquilin 2. Biochem. Biophys. Res. Commun. 2016;472:324&#x2013;331. doi: 10.1016/j.bbrc.2016.02.107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2016.02.107</ArticleId><ArticleId IdType="pubmed">26944018</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen W.C., Li H.Y., Chen G.C., Chern Y., Tu P.H. Mutations in the ubiquitin-binding domain of OPTN/optineurin interfere with autophagy-mediated degradation of misfolded proteins by a dominant-negative mechanism. Autophagy. 2015;11:685&#x2013;700. doi: 10.4161/auto.36098.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/auto.36098</ArticleId><ArticleId IdType="pmc">PMC4502753</ArticleId><ArticleId IdType="pubmed">25484089</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao J., Xia Q., Liu C., Ying Z., Wang H., Wang G. A critical role of Hrd1 in the regulation of optineurin degradation and aggresome formation. Hum. Mol. Genet. 2017;26:1877&#x2013;1889. doi: 10.1093/hmg/ddx096.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddx096</ArticleId><ArticleId IdType="pubmed">28334804</ArticleId></ArticleIdList></Reference><Reference><Citation>Wardman J.H., Henriksen E.E., Marthaler A.G., Nielsen J.E., Nielsen T.T. Enhancement of Autophagy and Solubilization of Ataxin-2 Alleviate Apoptosis in Spinocerebellar Ataxia Type 2 Patient Cells. Cerebellum. 2020;19:165&#x2013;181. doi: 10.1007/s12311-019-01092-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12311-019-01092-8</ArticleId><ArticleId IdType="pubmed">31898278</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Donkervoort S., Dec E., Badadani M., Katheria V., Rana P., Nguyen C., Mukherjee J., Caiozzo V., Martin B., et al. The multiple faces of valosin-containing protein-associated diseases: Inclusion body myopathy with Paget&#x2019;s disease of bone, frontotemporal dementia, and amyotrophic lateral sclerosis. J. Mol. Neurosci. 2011;45:522&#x2013;531. doi: 10.1007/s12031-011-9627-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12031-011-9627-y</ArticleId><ArticleId IdType="pubmed">21892620</ArticleId></ArticleIdList></Reference><Reference><Citation>Altmann C., Hardt S., Fischer C., Heidler J., Lim H.Y., H&#xe4;ussler A., Albuquerque B., Zimmer B., M&#xf6;ser C., Behrends C., et al. Progranulin overexpression in sensory neurons attenuates neuropathic pain in mice: Role of autophagy. Neurobiol. Dis. 2016;96:294&#x2013;311. doi: 10.1016/j.nbd.2016.09.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2016.09.010</ArticleId><ArticleId IdType="pubmed">27629805</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang N., Ma Q., Peng P., Yu Y., Xu S., Wang G., Ying Z., Wang H. Autophagy and Ubiquitin-Proteasome System Coordinate to Regulate the Protein Quality Control of Neurodegenerative Disease-Associated DCTN1. Neurotox. Res. 2020;37:48&#x2013;57. doi: 10.1007/s12640-019-00113-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12640-019-00113-y</ArticleId><ArticleId IdType="pubmed">31654383</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y., Halliday G.M., Kiernan M.C., Tan R.H. TDP-43 levels in the brain tissue of ALS cases with and without C9ORF72 or ATXN2 gene expansions. Neurology. 2019;93:e1748&#x2013;e1755. doi: 10.1212/WNL.0000000000008439.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000008439</ArticleId><ArticleId IdType="pubmed">31619481</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y.S., Kato M., Wu X., Litsios A., Sutter B.M., Wang Y., Hsu C.H., Wood N.E., Lemoff A., Mirzaei H., et al. Yeast Ataxin-2 Forms an Intracellular Condensate Required for the Inhibition of TORC1 Signaling during Respiratory Growth. Cell. 2019;177:697&#x2013;710.e17. doi: 10.1016/j.cell.2019.02.043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2019.02.043</ArticleId><ArticleId IdType="pmc">PMC6752053</ArticleId><ArticleId IdType="pubmed">30982600</ArticleId></ArticleIdList></Reference><Reference><Citation>Tresse E., Salomons F.A., Vesa J., Bott L.C., Kimonis V., Yao T.P., Dantuma N.P., Taylor J.P. VCP/p97 is essential for maturation of ubiquitin-containing autophagosomes and this function is impaired by mutations that cause IBMPFD. Autophagy. 2010;6:217&#x2013;227. doi: 10.4161/auto.6.2.11014.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/auto.6.2.11014</ArticleId><ArticleId IdType="pmc">PMC2929010</ArticleId><ArticleId IdType="pubmed">20104022</ArticleId></ArticleIdList></Reference><Reference><Citation>Papadopoulos C., Kirchner P., Bug M., Grum D., Koerver L., Schulze N., Poehler R., Dressler A., Fengler S., Arhzaouy K., et al. VCP/p97 cooperates with YOD1, UBXD1 and PLAA to drive clearance of ruptured lysosomes by autophagy. EMBO J. 2017;36:135&#x2013;150. doi: 10.15252/embj.201695148.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201695148</ArticleId><ArticleId IdType="pmc">PMC5242375</ArticleId><ArticleId IdType="pubmed">27753622</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu G., Byrd A., Warner A.N., Pei F., Basha E., Buchanan A., Buchan J.R. Cdc48/VCP and Endocytosis Regulate TDP-43 and FUS Toxicity and Turnover. Mol. Cell. Biol. 2020;40:e00256-19. doi: 10.1128/MCB.00256-19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.00256-19</ArticleId><ArticleId IdType="pmc">PMC6996276</ArticleId><ArticleId IdType="pubmed">31767634</ArticleId></ArticleIdList></Reference><Reference><Citation>Sleegers K., Brouwers N., Maurer-Stroh S., van Es M.A., Van Damme P., van Vught P.W., van der Zee J., Serneels S., De Pooter T., Van den Broeck M., et al. Progranulin genetic variability contributes to amyotrophic lateral sclerosis. Neurology. 2008;71:253&#x2013;259. doi: 10.1212/01.wnl.0000289191.54852.75.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000289191.54852.75</ArticleId><ArticleId IdType="pubmed">18184915</ArticleId></ArticleIdList></Reference><Reference><Citation>Pegat A., Bouhour F., Mouzat K., Vial C., Pegat B., Leblanc P., Broussolle E., Millecamps S., Lumbroso S., Bernard E. Electrophysiological Characterization of C9ORF72-Associated Amyotrophic Lateral Sclerosis: A Retrospective Study. Eur. Neurol. 2019;82:106&#x2013;112. doi: 10.1159/000505777.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000505777</ArticleId><ArticleId IdType="pubmed">32018264</ArticleId></ArticleIdList></Reference><Reference><Citation>Swinnen B., Bento-Abreu A., Gendron T.F., Boeynaems S., Bogaert E., Nuyts R., Timmers M., Scheveneels W., Hersmus N., Wang J., et al. A zebrafish model for C9orf72 ALS reveals RNA toxicity as a pathogenic mechanism. Acta Neuropathol. 2018;135:427&#x2013;443. doi: 10.1007/s00401-017-1796-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1796-5</ArticleId><ArticleId IdType="pubmed">29302778</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y., Zhou B., Lin M.Y., Wang S., Foust K.D., Sheng Z.H. Endolysosomal Deficits Augment Mitochondria Pathology in Spinal Motor Neurons of Asymptomatic fALS Mice. Neuron. 2015;87:355&#x2013;370. doi: 10.1016/j.neuron.2015.06.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2015.06.026</ArticleId><ArticleId IdType="pmc">PMC4511489</ArticleId><ArticleId IdType="pubmed">26182418</ArticleId></ArticleIdList></Reference><Reference><Citation>Natale G., Lenzi P., Lazzeri G., Falleni A., Biagioni F., Ryskalin L., Fornai F. Compartment-dependent mitochondrial alterations in experimental ALS, the effects of mitophagy and mitochondriogenesis. Front. Cell. Neurosci. 2015;9:434. doi: 10.3389/fncel.2015.00434.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2015.00434</ArticleId><ArticleId IdType="pmc">PMC4635226</ArticleId><ArticleId IdType="pubmed">26594150</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaughan S.K., Kemp Z., Hatzipetros T., Vieira F., Valdez G. Degeneration of proprioceptive sensory nerve endings in mice harboring amyotrophic lateral sclerosis-causing mutations. J. Comp. Neurol. 2015;523:2477&#x2013;2494. doi: 10.1002/cne.23848.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cne.23848</ArticleId><ArticleId IdType="pmc">PMC5759336</ArticleId><ArticleId IdType="pubmed">26136049</ArticleId></ArticleIdList></Reference><Reference><Citation>Limanaqi F., Gambardella S., Lazzeri G., Ferrucci M., Ruggieri S., Fornai F. Revisiting the gamma loop in ALS. Arch. Ital. Biol. 2017;155:118&#x2013;130. doi: 10.12871/00039829201748.</Citation><ArticleIdList><ArticleId IdType="doi">10.12871/00039829201748</ArticleId><ArticleId IdType="pubmed">29405034</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonini G., Gragnani F., Romaniello A., Pennisi E.M., Morino S., Ceschin V., Santoro L., Cruccu G. Sensory involvement in spinal-bulbar muscular atrophy (Kennedy&#x2019;s disease) Muscle Nerve. 2000;23:252&#x2013;258. doi: 10.1002/(SICI)1097-4598(200002)23:2&lt;252::AID-MUS17&gt;3.0.CO;2-P.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1097-4598(200002)23:2&lt;252::AID-MUS17&gt;3.0.CO;2-P</ArticleId><ArticleId IdType="pubmed">10639619</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng L., Liu J., Liu X., Wang Z., Yuan Y., Zhang W. Pathological features of muscles and peripheral nerves of Kennedy&#x2019;s disease: A report of 12 cases. Zhonghua Yi Xue Za Zhi. 2015;95:1681&#x2013;1685.</Citation><ArticleIdList><ArticleId IdType="pubmed">26675799</ArticleId></ArticleIdList></Reference><Reference><Citation>Laird A.S., Van Hoecke A., De Muynck L., Timmers M., Van den Bosch L., Van Damme P., Robberecht W. Progranulin is neurotrophic in vivo and protects against a mutant TDP-43 induced axonopathy. PLoS ONE. 2010;5:e13368. doi: 10.1371/journal.pone.0013368.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0013368</ArticleId><ArticleId IdType="pmc">PMC2954192</ArticleId><ArticleId IdType="pubmed">20967127</ArticleId></ArticleIdList></Reference><Reference><Citation>Rusmini P., Cortese K., Crippa V., Cristofani R., Cicardi M.E., Ferrari V., Vezzoli G., Tedesco B., Meroni M., Messi E., et al. Trehalose induces autophagy via lysosomal-mediated TFEB activation in models of motoneuron degeneration. Autophagy. 2019;15:631&#x2013;651. doi: 10.1080/15548627.2018.1535292.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2018.1535292</ArticleId><ArticleId IdType="pmc">PMC6526812</ArticleId><ArticleId IdType="pubmed">30335591</ArticleId></ArticleIdList></Reference><Reference><Citation>Castillo K., Nassif M., Valenzuela V., Rojas F., Matus S., Mercado G., Court F.A., van Zundert B., Hetz C. Trehalose delays the progression of amyotrophic lateral sclerosis by enhancing autophagy in motoneurons. Autophagy. 2013;9:1308&#x2013;1320. doi: 10.4161/auto.25188.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/auto.25188</ArticleId><ArticleId IdType="pubmed">23851366</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X., Chen S., Song L., Tang Y., Shen Y., Jia L., Le W. MTOR-independent, autophagic enhancer trehalose prolongs motor neuron survival and ameliorates the autophagic flux defect in a mouse model of amyotrophic lateral sclerosis. Autophagy. 2014;10:588&#x2013;602. doi: 10.4161/auto.27710.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/auto.27710</ArticleId><ArticleId IdType="pmc">PMC4091147</ArticleId><ArticleId IdType="pubmed">24441414</ArticleId></ArticleIdList></Reference><Reference><Citation>Holler C.J., Taylor G., McEachin Z.T., Deng Q., Watkins W.J., Hudson K., Easley C.A., Hu W.T., Hales C.M., Rossoll W., et al. Trehalose upregulates progranulin expression in human and mouse models of GRN haploinsufficiency: A novel therapeutic lead to treat frontotemporal dementia. Mol. Neurodegener. 2016;11:46. doi: 10.1186/s13024-016-0114-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-016-0114-3</ArticleId><ArticleId IdType="pmc">PMC4919863</ArticleId><ArticleId IdType="pubmed">27341800</ArticleId></ArticleIdList></Reference><Reference><Citation>Haidar M., Timmerman V. Autophagy as an emerging common pathomechanism in inherited peripheral neuropathies. Front. Mol. Neurosci. 2017;10:143. doi: 10.3389/fnmol.2017.00143.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2017.00143</ArticleId><ArticleId IdType="pmc">PMC5425483</ArticleId><ArticleId IdType="pubmed">28553203</ArticleId></ArticleIdList></Reference><Reference><Citation>Baldwin K.R., Godena V.K., Hewitt V.L., Whitworth A.J. Axonal transport defects are a common phenotype in Drosophila models of ALS. Hum. Mol. Genet. 2016;25:2378&#x2013;2392. doi: 10.1093/hmg/ddw105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddw105</ArticleId><ArticleId IdType="pmc">PMC5181624</ArticleId><ArticleId IdType="pubmed">27056981</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikenaka K., Katsuno M., Kawai K., Ishigaki S., Tanaka F., Sobue G. Disruption of axonal transport in motor neuron diseases. Int. J. Mol. Sci. 2012;13:1225&#x2013;1238. doi: 10.3390/ijms13011225.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms13011225</ArticleId><ArticleId IdType="pmc">PMC3269748</ArticleId><ArticleId IdType="pubmed">22312314</ArticleId></ArticleIdList></Reference><Reference><Citation>Str&#xf6;m A.L., Gal J., Shi P., Kasarskis E.J., Hayward L.J., Zhu H. Retrograde axonal transport and motor neuron disease. J. Neurochem. 2008;106:495&#x2013;505. doi: 10.1111/j.1471-4159.2008.05393.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2008.05393.x</ArticleId><ArticleId IdType="pmc">PMC4477783</ArticleId><ArticleId IdType="pubmed">18384644</ArticleId></ArticleIdList></Reference><Reference><Citation>Hafezparast M., Klocke R., Ruhrberg C., Marquardt A., Ahmad-Annuar A., Bowen S., Lalli G., Witherden A.S., Hummerich H., Nicholson S., et al. Mutations in dynein link motor neuron degeneration to defects in retrograde transport. Science. 2003;300:808&#x2013;812. doi: 10.1126/science.1083129.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1083129</ArticleId><ArticleId IdType="pubmed">12730604</ArticleId></ArticleIdList></Reference><Reference><Citation>Puls I., Oh S.J., Sumner C.J., Wallace K.E., Floeter M.K., Mann E.A., Kennedy W.R., Wendelschafer-Crabb G., Vortmeyer A., Powers R., et al. Distal spinal and bulbar muscular atrophy caused by dynactin mutation. Ann. Neurol. 2005;57:687&#x2013;694. doi: 10.1002/ana.20468.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.20468</ArticleId><ArticleId IdType="pmc">PMC1351270</ArticleId><ArticleId IdType="pubmed">15852399</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu J., Lai C., Shim H., Xie C., Sun L., Long C.X., Ding J., Li Y., Cai H. Genetic ablation of dynactin p150(Glued) in postnatal neurons causes preferential degeneration of spinal motor neurons in aged mice. Mol. Neurodegener. 2018;13:10. doi: 10.1186/s13024-018-0242-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-018-0242-z</ArticleId><ArticleId IdType="pmc">PMC5831668</ArticleId><ArticleId IdType="pubmed">29490687</ArticleId></ArticleIdList></Reference><Reference><Citation>Montie H.L., Cho M.S., Holder L., Liu Y., Tsvetkov A.S., Finkbeiner S., Merry D.E. Cytoplasmic retention of polyglutamine-expanded androgen receptor ameliorates disease via autophagy in a mouse model of spinal and bulbar muscular atrophy. Hum. Mol. Genet. 2009;18:1937&#x2013;1950. doi: 10.1093/hmg/ddp115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddp115</ArticleId><ArticleId IdType="pmc">PMC2678926</ArticleId><ArticleId IdType="pubmed">19279159</ArticleId></ArticleIdList></Reference><Reference><Citation>Giorgetti E., Rusmini P., Crippa V., Cristofani R., Boncoraglio A., Cicardi M.E., Galbiati M., Poletti A. Synergic prodegradative activity of Bicalutamide and trehalose on the mutant androgen receptor responsible for spinal and bulbar muscular atrophy. Hum. Mol. Genet. 2015;24:64&#x2013;75. doi: 10.1093/hmg/ddu419.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddu419</ArticleId><ArticleId IdType="pmc">PMC4262493</ArticleId><ArticleId IdType="pubmed">25122660</ArticleId></ArticleIdList></Reference><Reference><Citation>Waza M., Adachi H., Katsuno M., Minamiyama M., Sang C., Tanaka F., Inukai A., Doyu M., Sobue G. 17-AAG, an Hsp90 inhibitor, ameliorates polyglutamine-mediated motor neuron degeneration. Nat. Med. 2005;11:1088&#x2013;1095. doi: 10.1038/nm1298.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm1298</ArticleId><ArticleId IdType="pubmed">16155577</ArticleId></ArticleIdList></Reference><Reference><Citation>Rusmini P., Simonini F., Crippa V., Bolzoni E., Onesto E., Cagnin M., Sau D., Ferri N., Poletti A. 17-AAG increases autophagic removal of mutant androgen receptor in spinal and bulbar muscular atrophy. Neurobiol. Dis. 2011;41:83&#x2013;95. doi: 10.1016/j.nbd.2010.08.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2010.08.023</ArticleId><ArticleId IdType="pubmed">20816782</ArticleId></ArticleIdList></Reference><Reference><Citation>Rusmini P., Crippa V., Giorgetti E., Boncoraglio A., Cristofani R., Carra S., Poletti A. Clearance of the mutant androgen receptor in motoneuronal models of spinal and bulbar muscular atrophy. Neurobiol. Aging. 2013;34:2585&#x2013;2603. doi: 10.1016/j.neurobiolaging.2013.05.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2013.05.026</ArticleId><ArticleId IdType="pmc">PMC3748343</ArticleId><ArticleId IdType="pubmed">23810450</ArticleId></ArticleIdList></Reference><Reference><Citation>Beitel L.K., Alvarado C., Mokhtar S., Paliouras M., Trifiro M. Mechanisms mediating spinal and bulbar muscular atrophy: Investigations into polyglutamine-expanded androgen receptor function and dysfunction. Front. Neurol. 2013;4:53. doi: 10.3389/fneur.2013.00053.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2013.00053</ArticleId><ArticleId IdType="pmc">PMC3654311</ArticleId><ArticleId IdType="pubmed">23720649</ArticleId></ArticleIdList></Reference><Reference><Citation>Stenoien D.L., Cummings C.J., Adams H.P., Mancini M.G., Patel K., DeMartino G.N., Marcelli M., Weigel N.L., Mancini M.A. Polyglutamine-expanded androgen receptors form aggregates that sequester heat shock proteins, proteasome components and SRC-1, and are suppressed by the HDJ-2 chaperone. Hum. Mol. Genet. 1999;8:731&#x2013;741. doi: 10.1093/hmg/8.5.731.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/8.5.731</ArticleId><ArticleId IdType="pubmed">10196362</ArticleId></ArticleIdList></Reference><Reference><Citation>Heine E.M., Berger T.R., Pluciennik A., Orr C.R., Zboray L., Merry D.E. Proteasome-mediated proteolysis of the polyglutamine-expanded androgen receptor is a late event in spinal and bulbar muscular atrophy (SBMA) pathogenesis. J. Biol. Chem. 2015;290:12572&#x2013;12584. doi: 10.1074/jbc.M114.617894.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M114.617894</ArticleId><ArticleId IdType="pmc">PMC4432278</ArticleId><ArticleId IdType="pubmed">25795778</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Su G., Huang Z., Fan J., Wang Y. Cepharanthine hydrochloride degrades polyglutamine-expanded androgen receptor proteins through an autophagy pathway in neuron cells. Eur. J. Pharmacol. 2019;861:172534. doi: 10.1016/j.ejphar.2019.172534.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejphar.2019.172534</ArticleId><ArticleId IdType="pubmed">31310754</ArticleId></ArticleIdList></Reference><Reference><Citation>Pandey U.B., Nie Z., Batlevi Y., McCray B.A., Ritson G.P., Nedelsky N.B., Schwartz S.L., DiProspero N.A., Knight M.A., Schuldiner O., et al. HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS. Nature. 2007;447:859&#x2013;863. doi: 10.1038/nature05853.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature05853</ArticleId><ArticleId IdType="pubmed">17568747</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao J., Zhai B., Gygi S.P., Goldberg A.L. mTOR inhibition activates overall protein degradation by the ubiquitin proteasome system as well as by autophagy. Proc. Natl. Acad. Sci. USA. 2015;112:15790&#x2013;15797. doi: 10.1073/pnas.1521919112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1521919112</ArticleId><ArticleId IdType="pmc">PMC4703015</ArticleId><ArticleId IdType="pubmed">26669439</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazzeri G., Biagioni F., Fulceri F., Busceti C.L., Scavuzzo M.C., Ippolito C., Salvetti A., Lenzi P., Fornai F. mTOR Modulates Methamphetamine-Induced Toxicity through Cell Clearing Systems. Oxid. Med. Cell. Longev. 2018;2018:6124745. doi: 10.1155/2018/6124745.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2018/6124745</ArticleId><ArticleId IdType="pmc">PMC6311854</ArticleId><ArticleId IdType="pubmed">30647813</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki K., Katsuno M., Banno H., Takeuchi Y., Atsuta N., Ito M., Watanabe H., Yamashita F., Hori N., Nakamura T., et al. CAG repeat size correlates to electrophysiological motor and sensory phenotypes in SBMA. Brain. 2008;131:229&#x2013;239. doi: 10.1093/brain/awm289.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awm289</ArticleId><ArticleId IdType="pubmed">18056738</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M., Sobue G., Doyu M., Mukai E., Hashizume Y., Mitsuma T. Primary sensory neurons in X-linked recessive bulbospinal neuropathy: Histopathology and androgen receptor gene expression. Muscle Nerve. 1995;18:301&#x2013;308. doi: 10.1002/mus.880180306.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.880180306</ArticleId><ArticleId IdType="pubmed">7870107</ArticleId></ArticleIdList></Reference><Reference><Citation>Lieberman A.P. Spinal and bulbar muscular atrophy. Handb. Clin. Neurol. 2018;148:625&#x2013;632. doi: 10.1016/B978-0-444-64076-5.00040-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-444-64076-5.00040-5</ArticleId><ArticleId IdType="pubmed">29478604</ArticleId></ArticleIdList></Reference><Reference><Citation>Gray A.L., Annan L., Dick J.R.T., La Spada A.R., Hanna M.G., Greensmith L., Malik B. Deterioration of muscle force and contractile characteristics are early pathological events in spinal and bulbar muscular atrophy mice. Dis. Model Mech. 2020 doi: 10.1242/dmm.042424.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.042424</ArticleId><ArticleId IdType="pmc">PMC7272358</ArticleId><ArticleId IdType="pubmed">32152060</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L., Lin H.K., Hu Y.C., Xie S., Yang L., Chang C. Suppression of androgen receptor-mediated transactivation and cell growth by the glycogen synthase kinase 3 beta in prostate cells. J. Biol. Chem. 2004;279:32444&#x2013;32452. doi: 10.1074/jbc.M313963200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M313963200</ArticleId><ArticleId IdType="pubmed">15178691</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarkar S., Krishna G., Imarisio S., Saiki S., O&#x2019;Kane C.J., Rubinsztein D.C. A rational mechanism for combination treatment of Huntington&#x2019;s disease using lithium and rapamycin. Hum. Mol. Genet. 2008;17:170&#x2013;178. doi: 10.1093/hmg/ddm294.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddm294</ArticleId><ArticleId IdType="pubmed">17921520</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasquali L., Busceti C.L., Fulceri F., Paparelli A., Fornai F. Intracellular pathways underlying the effects of lithium. Behav. Pharmacol. 2010;21:473&#x2013;492. doi: 10.1097/FBP.0b013e32833da5da.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/FBP.0b013e32833da5da</ArticleId><ArticleId IdType="pubmed">20700048</ArticleId></ArticleIdList></Reference><Reference><Citation>Limanaqi F., Biagioni F., Ryskalin L., Busceti C.L., Fornai F. Molecular Mechanisms Linking ALS/FTD and Psychiatric Disorders, the Potential Effects of Lithium. Front. Cell. Neurosci. 2019;13:450. doi: 10.3389/fncel.2019.00450.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2019.00450</ArticleId><ArticleId IdType="pmc">PMC6797817</ArticleId><ArticleId IdType="pubmed">31680867</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin J.H., Cho S.I., Lim H.R., Lee J.K., Lee Y.A., Noh J.S., Joo I.S., Kim K.W., Gwag B.J. Concurrent administration of Neu2000 and lithium produces marked improvement of motor neuron survival, motor function, and mortality in a mouse model ofamyotrophic lateral sclerosis. Mol. Pharmacol. 2007;71:965&#x2013;975. doi: 10.1124/mol.106.030676.</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/mol.106.030676</ArticleId><ArticleId IdType="pubmed">17105868</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng H.L., Leng Y., Ma C.H., Zhang J., Ren M., Chuang D.M. Combined lithium and valproate treatment delays disease onset, reduces neurological deficits and prolongs survival in an amyotrophic lateral sclerosis mouse model. Neuroscience. 2008;155:567&#x2013;572. doi: 10.1016/j.neuroscience.2008.06.040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2008.06.040</ArticleId><ArticleId IdType="pmc">PMC2709275</ArticleId><ArticleId IdType="pubmed">18640245</ArticleId></ArticleIdList></Reference><Reference><Citation>Calder&#xf3; J., Brunet N., Tarabal O., Piedrafita L., Hereu M., Ayala V., Esquerda J.E. Lithium prevents excitotoxic cell death of motoneurons in organotypic slice cultures of spinal cord. Neuroscience. 2010;165:1353&#x2013;1369. doi: 10.1016/j.neuroscience.2009.11.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2009.11.034</ArticleId><ArticleId IdType="pubmed">19932742</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S.Y., Ren M., Jiang H.Z., Wang J., Jiang H.Q., Yin X., Qi Y., Wang X.D., Dong G.T., Wang T.H., et al. Notch pathway is activated in cell culture and mouse models of mutant SOD1-related familial amyotrophic lateral sclerosis, with suppression of its activation as an additional mechanism of neuroprotection for lithium and valproate. Neuroscience. 2015;301:276&#x2013;288. doi: 10.1016/j.neuroscience.2015.06.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2015.06.002</ArticleId><ArticleId IdType="pubmed">26067594</ArticleId></ArticleIdList></Reference><Reference><Citation>Boll M.C., Bayliss L., Vargas-Ca&#xf1;as S., Burgos J., Montes S., Pe&#xf1;aloza-Solano G., Rios C., Alcaraz-Zubeldia M. Clinical and biological changes under treatment with lithium carbonate and valproic acid in sporadic amyotrophic lateral sclerosis. J. Neurol. Sci. 2014;340:103&#x2013;108. doi: 10.1016/j.jns.2014.03.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2014.03.005</ArticleId><ArticleId IdType="pubmed">24667005</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Eijk R.P.A., Jones A.R., Sproviero W., Shatunov A., Shaw P.J., Leigh P.N., Young C.A., Shaw C.E., Mora G., Mandrioli J., et al. Meta-analysis of pharmacogenetic interactions in amyotrophic lateral sclerosis clinical trials. Neurology. 2017;89:1915&#x2013;1922. doi: 10.1212/WNL.0000000000004606.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000004606</ArticleId><ArticleId IdType="pmc">PMC5664299</ArticleId><ArticleId IdType="pubmed">28978660</ArticleId></ArticleIdList></Reference><Reference><Citation>Terracciano C., Nogalska A., Engel W.K., Askanas V. In AbetaPP-overexpressing cultured human muscle fibers proteasome inhibition enhances phosphorylation of AbetaPP751 and GSK3beta activation: Effects mitigated by lithium and apparently relevant to sporadic inclusion-body myositis. J. Neurochem. 2010;112:389&#x2013;396. doi: 10.1111/j.1471-4159.2009.06461.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2009.06461.x</ArticleId><ArticleId IdType="pmc">PMC2809129</ArticleId><ArticleId IdType="pubmed">19878439</ArticleId></ArticleIdList></Reference><Reference><Citation>Nath S.R., Yu Z., Gipson T.A., Marsh G.B., Yoshidome E., Robins D.M., Todi S.V., Housman D.E., Lieberman A.P. Androgen receptor polyglutamine expansion drives age-dependent quality control defects and muscle dysfunction. J. Clin. Investig. 2018;128:3630&#x2013;3641. doi: 10.1172/JCI99042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI99042</ArticleId><ArticleId IdType="pmc">PMC6063498</ArticleId><ArticleId IdType="pubmed">29809168</ArticleId></ArticleIdList></Reference><Reference><Citation>Palazzolo I., Stack C., Kong L., Musaro A., Adachi H., Katsuno M., Sobue G., Taylor J.P., Sumner C.J., Fischbeck K.H., et al. Overexpression of IGF-1 in muscle attenuates disease in a mouse model of spinal and bulbar muscular atrophy. Neuron. 2009;63:316&#x2013;328. doi: 10.1016/j.neuron.2009.07.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2009.07.019</ArticleId><ArticleId IdType="pmc">PMC2735765</ArticleId><ArticleId IdType="pubmed">19679072</ArticleId></ArticleIdList></Reference><Reference><Citation>Rusmini P., Polanco M.J., Cristofani R., Cicardi M.E., Meroni M., Galbiati M., Piccolella M., Messi E., Giorgetti E., Lieberman A.P., et al. Aberrant Autophagic Response in The Muscle of A Knock-in Mouse Model of Spinal and Bulbar Muscular Atrophy. Sci. Rep. 2015;5:15174. doi: 10.1038/srep15174.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep15174</ArticleId><ArticleId IdType="pmc">PMC4614888</ArticleId><ArticleId IdType="pubmed">26490709</ArticleId></ArticleIdList></Reference><Reference><Citation>Chevalier-Larsen E.S., Wallace K.E., Pennise C.R., Holzbaur E.L. Lysosomal proliferation and distal degeneration in motor neurons expressing the G59S mutation in the p150Glued subunit of dynactin. Hum. Mol. Genet. 2008;17:1946&#x2013;1955. doi: 10.1093/hmg/ddn092.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddn092</ArticleId><ArticleId IdType="pmc">PMC2584350</ArticleId><ArticleId IdType="pubmed">18364389</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox L.E., Ferraiuolo L., Goodall E.F., Heath P.R., Higginbottom A., Mortiboys H., Hollinger H.C., Hartley J.A., Brockington A., Burness C.E., et al. Mutations in CHMP2B in lower motor neuron predominant amyotrophic lateral sclerosis (ALS) PLoS ONE. 2010;5:e9872. doi: 10.1371/journal.pone.0009872.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0009872</ArticleId><ArticleId IdType="pmc">PMC2844426</ArticleId><ArticleId IdType="pubmed">20352044</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen W., Ganetzky B. Autophagy promotes synapse development in Drosophila. J. Cell Biol. 2009;187:71&#x2013;79. doi: 10.1083/jcb.200907109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.200907109</ArticleId><ArticleId IdType="pmc">PMC2762098</ArticleId><ArticleId IdType="pubmed">19786572</ArticleId></ArticleIdList></Reference><Reference><Citation>Stavoe A.K., Hill S.E., Hall D.H., Col&#xf3;n-Ramos D.A. KIF1A/UNC-104 Transports ATG-9 to Regulate Neurodevelopment and Autophagy at Synapses. Dev. Cell. 2016;38:171&#x2013;185. doi: 10.1016/j.devcel.2016.06.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.devcel.2016.06.012</ArticleId><ArticleId IdType="pmc">PMC4961624</ArticleId><ArticleId IdType="pubmed">27396362</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhattacharya M.R.C., Geisler S.M., Pittman S.K., Doan R.A., Weihl C.C., Milbrandt J., DiAntonio A. TMEM184b Promotes Axon Degeneration and Neuromuscular Junction Maintenance. J. Neurosci. 2016;36:4681&#x2013;4689. doi: 10.1523/JNEUROSCI.2893-15.2016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2893-15.2016</ArticleId><ArticleId IdType="pmc">PMC4846669</ArticleId><ArticleId IdType="pubmed">27122027</ArticleId></ArticleIdList></Reference><Reference><Citation>Ju J.S., Fuentealba R.A., Miller S.E., Jackson E., Piwnica-Worms D., Baloh R.H., Weihl C.C. Valosin-containing protein (VCP) is required for autophagy and is disrupted in VCP disease. J. Cell. Biol. 2009;187:875&#x2013;888. doi: 10.1083/jcb.200908115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.200908115</ArticleId><ArticleId IdType="pmc">PMC2806317</ArticleId><ArticleId IdType="pubmed">20008565</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik I., Turk J., Mancuso D.J., Montier L., Wohltmann M., Wozniak D.F., Schmidt R.E., Gross R.W., Kotzbauer P.T. Disrupted membrane homeostasis and accumulation of ubiquitinated proteins in a mouse model of infantile neuroaxonal dystrophy caused by PLA2G6 mutations. Am. J. Pathol. 2008;172:406&#x2013;416. doi: 10.2353/ajpath.2008.070823.</Citation><ArticleIdList><ArticleId IdType="doi">10.2353/ajpath.2008.070823</ArticleId><ArticleId IdType="pmc">PMC2312364</ArticleId><ArticleId IdType="pubmed">18202189</ArticleId></ArticleIdList></Reference><Reference><Citation>Sumi-Akamaru H., Beck G., Kato S., Mochizuki H. Neuroaxonal dystrophy in PLA2G6 knockout mice. Neuropathology. 2015;35:289&#x2013;302. doi: 10.1111/neup.12202.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/neup.12202</ArticleId><ArticleId IdType="pubmed">25950622</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen P.C., Qin L.N., Li X.M., Walters B.J., Wilson J.A., Mei L., Wilson S.M. The proteasome-associated deubiquitinating enzyme Usp14 is essential for the maintenance of synaptic ubiquitin levels and the development of neuromuscular junctions. J. Neurosci. 2009;29:10909&#x2013;10919. doi: 10.1523/JNEUROSCI.2635-09.2009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2635-09.2009</ArticleId><ArticleId IdType="pmc">PMC2766780</ArticleId><ArticleId IdType="pubmed">19726649</ArticleId></ArticleIdList></Reference><Reference><Citation>Limanaqi F., Biagioni F., Busceti C.L., Ryskalin L., Fornai F. The effects of proteasome on baseline and methamphetamine-dependent dopamine transmission. Neurosci. Biobehav. Rev. 2019;102:308&#x2013;317. doi: 10.1016/j.neubiorev.2019.05.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neubiorev.2019.05.008</ArticleId><ArticleId IdType="pubmed">31095962</ArticleId></ArticleIdList></Reference><Reference><Citation>Limanaqi F., Biagioni F., Busceti C.L., Ryskalin L., Soldani P., Frati A., Fornai F. Cell Clearing Systems Bridging Neuro-Immunity and Synaptic Plasticity. Int. J. Mol. Sci. 2019;20:2197. doi: 10.3390/ijms20092197.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20092197</ArticleId><ArticleId IdType="pmc">PMC6538995</ArticleId><ArticleId IdType="pubmed">31060234</ArticleId></ArticleIdList></Reference><Reference><Citation>Limanaqi F., Biagioni F., Gambardella S., Ryskalin L., Fornai F. Interdependency Between Autophagy and Synaptic Vesicle Trafficking: Implications for Dopamine Release. Front. Mol. Neurosci. 2018;11:299. doi: 10.3389/fnmol.2018.00299.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2018.00299</ArticleId><ArticleId IdType="pmc">PMC6110820</ArticleId><ArticleId IdType="pubmed">30186112</ArticleId></ArticleIdList></Reference><Reference><Citation>Hernandez D., Torres C.A., Setlik W., Cebri&#xe1;n C., Mosharov E.V., Tang G., Cheng H.C., Kholodilov N., Yarygina O., Burke R.E., et al. Regulation of presynaptic neurotransmission by macroautophagy. Neuron. 2012;74:277&#x2013;284. doi: 10.1016/j.neuron.2012.02.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2012.02.020</ArticleId><ArticleId IdType="pmc">PMC3578406</ArticleId><ArticleId IdType="pubmed">22542182</ArticleId></ArticleIdList></Reference><Reference><Citation>Bachiller S., Rybkina T., Porras-Garc&#xed;a E., P&#xe9;rez-Villegas E., Tabares L., Armengol J.A., Carri&#xf3;n A.M., Ruiz R. The HERC1 E3 Ubiquitin Ligase is essential for normal development and for neurotransmission at the mouse neuromuscular junction. Cell. Mol. Life Sci. 2015;72:2961&#x2013;2971. doi: 10.1007/s00018-015-1878-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-015-1878-2</ArticleId><ArticleId IdType="pubmed">25746226</ArticleId></ArticleIdList></Reference><Reference><Citation>Aravamudan B., Broadie K. Synaptic Drosophila UNC-13 is regulated by antagonistic G-protein pathways via a proteasome-dependent degradation mechanism. J. Neurobiol. 2003;54:417&#x2013;438. doi: 10.1002/neu.10142.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/neu.10142</ArticleId><ArticleId IdType="pubmed">12532395</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan M.M., Strack S., Wild F., Hanashima A., Gasch A., Brohm K., Reischl M., Carnio S., Labeit D., Sandri M., et al. Role of autophagy, SQSTM1, SH3GLB1, and TRIM63 in the turnover of nicotinic acetylcholine receptors. Autophagy. 2014;10:123&#x2013;136. doi: 10.4161/auto.26841.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/auto.26841</ArticleId><ArticleId IdType="pmc">PMC4389866</ArticleId><ArticleId IdType="pubmed">24220501</ArticleId></ArticleIdList></Reference><Reference><Citation>Wild F., Khan M.M., Straka T., Rudolf R. Progress of endocytic CHRN to autophagic degradation is regulated by RAB5-GTPase and T145 phosphorylation of SH3GLB1 at mouse neuromuscular junctions in vivo. Autophagy. 2016;12:2300&#x2013;2310. doi: 10.1080/15548627.2016.1234564.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2016.1234564</ArticleId><ArticleId IdType="pmc">PMC5173261</ArticleId><ArticleId IdType="pubmed">27715385</ArticleId></ArticleIdList></Reference><Reference><Citation>Rezvani K., Teng Y., De Biasi M. The ubiquitin-proteasome system regulates the stability of neuronal nicotinic acetylcholine receptors. J. Mol. Neurosci. 2010;40:177&#x2013;184. doi: 10.1007/s12031-009-9272-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12031-009-9272-x</ArticleId><ArticleId IdType="pmc">PMC3119567</ArticleId><ArticleId IdType="pubmed">19693707</ArticleId></ArticleIdList></Reference><Reference><Citation>Rezvani K., Teng Y., Pan Y., Dani J.A., Lindstrom J., Garc&#xed;a Gras E.A., McIntosh J.M., De Biasi M. UBXD4, a UBX-containing protein, regulates the cell surface number and stability of alpha3-containing nicotinic acetylcholine receptors. J. Neurosci. 2009;29:6883&#x2013;6896. doi: 10.1523/JNEUROSCI.4723-08.2009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.4723-08.2009</ArticleId><ArticleId IdType="pmc">PMC2935801</ArticleId><ArticleId IdType="pubmed">19474315</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabatelli M., Eusebi F., Al-Chalabi A., Conte A., Madia F., Luigetti M., Mancuso I., Limatola C., Trettel F., Sobrero F., et al. Rare missense variants of neuronal nicotinic acetylcholine receptor altering receptor function are associated with sporadic amyotrophic lateral sclerosis. Hum. Mol. Genet. 2009;18:3997&#x2013;4006. doi: 10.1093/hmg/ddp339.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddp339</ArticleId><ArticleId IdType="pubmed">19628475</ArticleId></ArticleIdList></Reference><Reference><Citation>Monks D.A., Johansen J.A., Mo K., Rao P., Eagleson B., Yu Z., Lieberman A.P., Breedlove S.M., Jordan C.L. Overexpression of wild-type androgen receptor in muscle recapitulates polyglutamine disease. Proc. Natl. Acad. Sci. USA. 2007;104:18259&#x2013;18264. doi: 10.1073/pnas.0705501104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0705501104</ArticleId><ArticleId IdType="pmc">PMC2084330</ArticleId><ArticleId IdType="pubmed">17984063</ArticleId></ArticleIdList></Reference><Reference><Citation>Poort J.E., Rheuben M.B., Breedlove S.M., Jordan C.L. Neuromuscular junctions are pathological but not denervated in two mouse models of spinal bulbar muscular atrophy. Hum. Mol. Genet. 2016;25:3768&#x2013;3783. doi: 10.1093/hmg/ddw222.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddw222</ArticleId><ArticleId IdType="pmc">PMC5216617</ArticleId><ArticleId IdType="pubmed">27493028</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Z., Je H.S., Young P., Gross J., Lu B., Feng G. Regulation of synaptic growth and maturation by a synapse-associated E3 ubiquitin ligase at the neuromuscular junction. J. Cell. Biol. 2007;177:1077&#x2013;1089. doi: 10.1083/jcb.200610060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.200610060</ArticleId><ArticleId IdType="pmc">PMC2064367</ArticleId><ArticleId IdType="pubmed">17576800</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan M.M., Lustrino D., Silveira W.A., Wild F., Straka T., Issop Y., O&#x2019;Connor E., Cox D., Reischl M., Marquardt T., et al. Sympathetic innervation controls homeostasis of neuromuscular junctions in health and disease. Proc. Natl. Acad. Sci. USA. 2016;113:746&#x2013;750. doi: 10.1073/pnas.1524272113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1524272113</ArticleId><ArticleId IdType="pmc">PMC4725522</ArticleId><ArticleId IdType="pubmed">26733679</ArticleId></ArticleIdList></Reference><Reference><Citation>Salazar G., Cullen A., Huang J., Zhao Y., Serino A., Hilenski L., Patrushev N., Forouzandeh F., Hwang H.S. SQSTM1/p62 and PPARGC1A/PGC-1alpha at the interface of autophagy and vascular senescence. Autophagy. 2019 doi: 10.1080/15548627.2019.1659612.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2019.1659612</ArticleId><ArticleId IdType="pmc">PMC7469683</ArticleId><ArticleId IdType="pubmed">31441382</ArticleId></ArticleIdList></Reference><Reference><Citation>Trausch-Azar J., Leone T.C., Kelly D.P., Schwartz A.L. Ubiquitin proteasome-dependent degradation of the transcriptional coactivator PGC-1{alpha} via the N-terminal pathway. J. Biol. Chem. 2010;285:40192&#x2013;40200. doi: 10.1074/jbc.M110.131615.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110.131615</ArticleId><ArticleId IdType="pmc">PMC3001001</ArticleId><ArticleId IdType="pubmed">20713359</ArticleId></ArticleIdList></Reference><Reference><Citation>Farah B.L., Sinha R.A., Wu Y., Singh B.K., Zhou J., Bay B.H., Yen P.M. &#x3b2;-Adrenergic agonist and antagonist regulation of autophagy in HepG2 cells, primary mouse hepatocytes, and mouse liver. PLoS ONE. 2014;9:e98155. doi: 10.1371/journal.pone.0098155.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0098155</ArticleId><ArticleId IdType="pmc">PMC4064960</ArticleId><ArticleId IdType="pubmed">24950230</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhi X., Li B., Li Z., Zhang J., Yu J., Zhang L., Xu Z. Adrenergic modulation of AMPK-dependent autophagy by chronic stress enhances cell proliferation and survival in gastric cancer. Int. J. Oncol. 2019;54:1625&#x2013;1638. doi: 10.3892/ijo.2019.4753.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ijo.2019.4753</ArticleId><ArticleId IdType="pmc">PMC6438426</ArticleId><ArticleId IdType="pubmed">30896863</ArticleId></ArticleIdList></Reference><Reference><Citation>Joassard O.R., Amirouche A., Gallot Y.S., Desgeorges M.M., Castells J., Durieux A.C., Berthon P., Freyssenet D.G. Regulation of Akt-mTOR, ubiquitin-proteasome and autophagy-lysosome pathways in response to formoterol administration in rat skeletal muscle. Int. J. Biochem. Cell. Biol. 2013;45:2444&#x2013;2455. doi: 10.1016/j.biocel.2013.07.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biocel.2013.07.019</ArticleId><ArticleId IdType="pubmed">23916784</ArticleId></ArticleIdList></Reference><Reference><Citation>Cristofani R., Crippa V., Vezzoli G., Rusmini P., Galbiati M., Cicardi M.E., Meroni M., Ferrari V., Tedesco B., Piccolella M., et al. The small heat shock protein B8 (HSPB8) efficiently removes aggregating species of dipeptides produced in C9ORF72-related neurodegenerative diseases. Cell Stress Chaperones. 2018;23:1&#x2013;12. doi: 10.1007/s12192-017-0806-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12192-017-0806-9</ArticleId><ArticleId IdType="pmc">PMC5741577</ArticleId><ArticleId IdType="pubmed">28608264</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakae N., Bieniek K.F., Zhang Y.J., Ross K., Gendron T.F., Murray M.E., Rademakers R., Petrucelli L., Dickson D.W. Poly-GR dipeptide repeat polymers correlate with neurodegeneration and Clinicopathological subtypes in C9ORF72-related brain disease. Acta Neuropathol. Commun. 2018;6:63. doi: 10.1186/s40478-018-0564-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-018-0564-7</ArticleId><ArticleId IdType="pmc">PMC6054740</ArticleId><ArticleId IdType="pubmed">30029693</ArticleId></ArticleIdList></Reference><Reference><Citation>Scaramuzzino C., Monaghan J., Milioto C., Lanson N.A., Jr., Maltare A., Aggarwal T., Casci I., Fackelmayer F.O., Pennuto M., Pandey U.B. Protein arginine methyltransferase 1 and 8 interact with FUS to modify its sub-cellular distribution and toxicity in vitro and in vivo. PLoS ONE. 2013;8:e61576. doi: 10.1371/journal.pone.0061576.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0061576</ArticleId><ArticleId IdType="pmc">PMC3631215</ArticleId><ArticleId IdType="pubmed">23620769</ArticleId></ArticleIdList></Reference><Reference><Citation>Li S., Yang P., Tian E., Zhang H. Arginine methylation modulates autophagic degradation of PGL granules in C. elegans. Mol. Cell. 2013;52:421&#x2013;433. doi: 10.1016/j.molcel.2013.09.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2013.09.014</ArticleId><ArticleId IdType="pubmed">24140420</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>